<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Poliomyelitis</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Poliomyelitis.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/diseases/poliomyelitis.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Progress toward poliomyelitis eradication — January 2023–December 2024</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s13690-026-02047-2-9b6ef2f5/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s13690-026-02047-2-9b6ef2f5/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings highlight the continued risk posed by persistent WPV1 transmission in endemic areas and the geographic spread of cVDPVs, informing the need for improved campaign quality, sustained surveillance, expanded nOPV2 use where cVDPV2 transmission persists, and strategic resource allocation under declining global health funding.</description>
    <category>Poliomyelitis</category>
    <category>Acute flaccid paralysis</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Vaccination policies for healthcare personnel in Europe, 2026</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128839-f5b67b79/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128839-f5b67b79/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings highlight persistent variation in healthcare worker vaccination policies across Europe despite recent expansion. The authors note that harmonized, evidence-based policies are needed to protect both healthcare personnel and patients amid resurgence of vaccine-preventable diseases.</description>
    <category>COVID-19</category>
    <category>Pertussis</category>
    <category>Diphtheria</category>
    <category>Influenza</category>
    <category>Tetanus</category>
    <category>Zoster</category>
    <category>Hepatitis A</category>
    <category>Tuberculosis</category>
    <category>Mumps</category>
    <category>Rubella</category>
    <category>Varicella</category>
    <category>Hepatitis B</category>
    <category>Poliomyelitis</category>
    <category>Measles</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Strategies and lessons learned from a type 1 circulating vaccine-derived poliovirus (cVDPV) outbreak affecting adult population: Madagascar, 2020–2023</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128987-b008ba26/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128987-b008ba26/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings demonstrate that polio outbreaks can involve significant adult populations with high mortality, supporting the need for inclusive vaccination strategies that target all age groups rather than exclusively children.</description>
    <category>Poliomyelitis</category>
    <category>Acute flaccid paralysis</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Vaccine-preventable disease outbreaks in schools, part 2: pertussis, meningococcal disease, diphtheria, poliomyelitis, hepatitis A, and rotavirus infection</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128750-3c0b0e8a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128750-3c0b0e8a/</guid>
    <pubDate>Mon, 01 Jun 2026 00:00:00 GMT</pubDate>
    <description>The review frames schools as environments where vaccine-preventable diseases can spread and where outbreaks can disrupt normal activities. It also states that falling vaccination coverage may increase outbreak risk and that vaccination services, surveillance, and diagnostic capacity should be strengthened.</description>
    <category>Poliomyelitis</category>
    <category>Pertussis</category>
    <category>Diphtheria</category>
    <category>Meningococcal disease</category>
    <category>Rotavirus infection</category>
    <category>Hepatitis A</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2023–June 2024</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7341a1-a6338068/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7341a1-a6338068/</guid>
    <pubDate>Thu, 17 Oct 2024 00:00:00 GMT</pubDate>
    <description>The report underscores that cVDPVs cause paralytic polio and asymptomatic transmission in undervaccinated communities, requiring timely resource allocation and high-quality outbreak responses to prevent international spread and achieve transmission control.</description>
    <category>Poliomyelitis</category>
    <category>Gastroenteritis</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-06-006-6f3ef0e0/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-06-006-6f3ef0e0/</guid>
    <pubDate>Mon, 01 Aug 2022 00:00:00 GMT</pubDate>
    <description>Inactivated viral vaccine technology has been applied to diseases of global health threat, and this chikungunya vaccine candidate offers an effective, flexible system for high-yield manufacturing with favorable stability for distribution.</description>
    <category>Chikungunya</category>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Poliomyelitis</category>
    <category>Influenza</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Vaccine safety</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1126-science-aba1238-2e0f2d50/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1126-science-aba1238-2e0f2d50/</guid>
    <pubDate>Fri, 24 Apr 2020 00:00:00 GMT</pubDate>
    <description>The findings are framed around the threat that circulating VDPV2 poses to polio eradication and the need for a new oral polio vaccine together with a contingency strategy, given that current outbreak response tools may themselves contribute to ongoing transmission.</description>
    <category>Poliomyelitis</category>
    <category>Gastroenteritis</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900–2015</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2018-01-065-bc387b6f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2018-01-065-bc387b6f/</guid>
    <pubDate>Thu, 01 Mar 2018 00:00:00 GMT</pubDate>
    <description>The authors frame universal vaccination programs as a highly effective prevention tool and emphasize that health authorities should reinforce public confidence in vaccines by communicating the scientific evidence of their benefits.</description>
    <category>Measles</category>
    <category>Diphtheria</category>
    <category>Rubella</category>
    <category>Poliomyelitis</category>
    <category>Mumps</category>
    <category>Hepatitis B</category>
    <category>Pertussis</category>
    <category>Meningococcal disease</category>
    <category>Tetanus</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Mandatory and recommended vaccination in the EU, Iceland and Norway: results of the VENICE 2010 survey on the ways of implementing national vaccination programmes</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-ese-17-22-20183-en-1c0d334e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-ese-17-22-20183-en-1c0d334e/</guid>
    <pubDate>Thu, 31 May 2012 00:00:00 GMT</pubDate>
    <description>The findings provide comparative information about European vaccination strategies, suggesting that understanding diverse approaches may help countries adapt their programmes. High compliance has been achieved in many European programmes using only recommendations rather than mandates.</description>
    <category>Influenza</category>
    <category>Gastroenteritis</category>
    <category>Poliomyelitis</category>
    <category>Hepatitis B</category>
    <category>Diphtheria</category>
    <category>Tetanus</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Climate and environment</category>
    <category>Guideline</category>
  </item>
</channel>
</rss>
